Indigo International, Corp.: Schedule 13D - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
Under the Securities Exchange Act of 1934

INDIGO INTERNATIONAL CORP.
(Name of Issuer)

Common Stock, $0.001 Par Value
(Title of Class of Securities)

45569A 105
(CUSIP Number)

copy to:
Bernard Pinsky
c/o Clark Wilson LLP
800-885 West Georgia Street, Vancouver, BC V6C 3H1
604-687-5600
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

October 25, 2011
(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d -1(e), 240.13d -1(f) or 240.13d -1(g), check the following box [ ].

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See 240.13d -7(b) for other parties to whom copies are to be sent.

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


SCHEDULE 13D

CUSIP No.      45569A 105

1        NAMES OF REPORTING PERSONS
         I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
         Odelio R. Arouca
2        CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
         (a) [ ]
         (b) [ ]
3        SEC USE ONLY
   
4        SOURCE OF FUNDS (See Instructions)
         PF
5          CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                                                        [ ]
6        CITIZENSHIP OR PLACE OF ORGANIZATION
         Odelio Aroucais a Brazilian citizen
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 7        SOLE VOTING POWER
         3,000,000
 8        SHARED VOTING POWER
         Nil
 9        SOLE DISPOSITIVE POWER
         3,000,000
10        SHARED DISPOSITIVE POWER
         Nil
11        AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,000,000 shares of common stock
12        CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
         N/A   [ ]
13        PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
         66.51% based on 4,510,000 of shares of common stock issued and outstanding as of October 31, 2011.
14        TYPE OF REPORTING PERSON (See Instructions)
         IN


Page 3

This Schedule 13D is being filed on behalf of Odelio Arouca (the “Reporting Person”) relating to the shares of common stock, par value $0.001 of Indigo International, Corp., a corporation existing under the laws of the State of Nevada (the “Issuer”).

Item 1. Security and Issuer

This Statement relates to shares of common stock with $0.001 par value of the Issuer. The principal executive offices of the Issuer are located at Regus Continental Square, Rua Olimpíadas, 205 - 4th Floor, Vila Olímpia, São Paulo, Brazil 04551-000.

Item 2. Identity and Background

  (a)

Odelio Arouca

     
  (b)

Mr. Arouca’s address is Regus Continental Square, Rua Olimpíadas, 205 - 4th Floor, Vila Olímpia, São Paulo, Brazil 04551-000

     
  (c)

Mr. Arouca is the CEO, CFO, Treasurer, Secretary and a director of the Issuer.

     
  (d)

During the last five years, Odelio Arouca has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     
  (e)

During the past five years, Odelio Arouca has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws

Item 3. Source and Amount of Funds or Other Considerations

Effective October 25, 2011, Odelio Arouca acquired 3,000,000 shares of common stock from one affiliate shareholder of the Company pursuant to a reorganization described under Item 4 “Purpose of Transaction”.

Item 4. Purpose of Transaction

Effective October 25, 2011, Ireneusz Nawrot, as vendor, entered into an affiliate stock purchase agreement with Odelio Arouca, whereby the vendor sold, assigned, transferred and delivered a total of 3,000,000 restricted shares of the Issuer to Mr. Arouca for a price of $0.01 per share.

Depending on market conditions and other factors, the Reporting Person may acquire additional shares of the Issuer’s common stock as it deems appropriate, whether in open market purchases, privately negotiated transactions or otherwise. The Reporting Person also reserves the right to dispose of some or all of the shares in the open market, in privately negotiated transactions to third parties or otherwise.

The acquisition was completed as part of a reorganization of the Issuer whereby Odelio Arouca was appointed as director and officer, the previous sole director and officer Ireneusz Nawrot resigned as an officer of the Issuer. Full details of the reorganization are contained in the report on form 8-K filed by the Company on October 31, 2011.

As of the date hereof, except as described above, the Reporting Person does not have any plans or proposals which relate to or would result in:


Page 4

Item 5. Interest in Securities of the Issuer

The aggregate number and percentage of common stock of the Issuer beneficially owned by the Reporting Person is 3,000,000 shares of common stock, or 66.51% based on 4,510,000 of shares of common stock issued and outstanding as of October 31, 2011.

All of the 3,000,000 shares are registered in the name of Odelio Arouca who has the sole power to vote or direct the vote, and to dispose or direct the disposition, of 3,000,000 shares of common stock of the Issuer. No person, other than the Reporting Person, is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the 3,000,000 shares of common stock of the Issuer.

The Reporting Person has not effected any transaction in the shares of common stock of the Issuer in the past 60 days.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Except as set forth above or set forth in the exhibits, there are no contracts, arrangements, understandings or relationships between the Reporting Person and any other person with respect to any securities of the Issuer.

Item 7. Material to Be Filed as Exhibits

10.1 Affiliate Stock Purchase Agreement dated October 25, 2011 between Ireneusz Antoni Nawrot and Odelio Arouca (incorporated by reference to the current report on Form 8-K filed by the Issuer on October 31, 2011).


Page 5

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief of each of the undersigned, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

October 31, 2011

/s/ Odelio R. Arouca
Signature

Odelio R. Arouca
Name/Title

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations
(See 18 U.S.C. 1001).